GlassScriptPrepare for your visit
Albert C Lockhart
Medical Oncology · Charleston, SC · NPI 1437233533
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$53,891.12
in general payments reported to CMS, 2019-2025 · $20K in 2025
The $20K reported for 2025 was more than what 88% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Who reported paying
General payments only, top 6 by amount.
- Ipsen Biopharmaceuticals, INC $19,205.11
- Beone Medicines USA, INC. $17,836.43
- Novartis Pharmaceuticals Corporation $8,125.00
- Siemens Medical Solutions USA, INC. $2,926.14
- E.R. Squibb & Sons, L.L.C. $2,460.21
- Beigene USA, INC. $2,000.00
Drugs and devices associated with these payments
Tevimbra Onivyde Somatuline Depot Xt Cdx Cablivi Enjaymo Venclexta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Albert Lockhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1087234/albert-c-lockhart